This post is from a low-reputation account and contains an unverified outbound link. Be cautious before clicking external links.
Combination Therapy with Aromatase Inhibitors in Postmenopausal Breast Cancer
Words
47
Reading
1 min
Listen
Play
2y
Combination therapy, utilizing Aromatase Inhibitors (AIs) alongside targeted agents, has emerged as one of the promising approaches in the treatment of hormone-sensitive breast cancer in postmenopausal women. This is because endocrine or hormonal therapy was found effective in hormone-sensitive breast cancer for a considerable period of time.